Aurobindo Pharma Limited (AUROPHARMA.BO)

1.238,90 +26,05 (+2,15%) Börsenschluss: 03:29PM IST

Aurobindo Pharma Limited

Galaxy, Plot No. 1
22nd-24th Floor Plot No.1, Survey No.83/1 Hyderabad Knowledge City,Raidurg Panmakt
Hyderabad 500032
India
91 40 6672 5000
https://www.aurobindo.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Kambam Nityananda Reddy	Vice Chairman & MD	37,41M	N/A	1958
Mr. Mettu Madan Mohan Reddy	Whole-Time Director	52,35M	N/A	1960
Mr. Santhanam Subramanian	Chief Financial Officer	21,06M	N/A	1961
Mr. Sanjeev Indravadan Dani	COO & Head of Formulations	N/A	N/A	1960
Dr. S. Vijaya Kumar	President of Technical	N/A	N/A	1966
Mr. Arvind Bothra	Head of Investor Relations & Corporate Communications	N/A	N/A	N/A
Mr. B. Adi Reddy	Compliance Officer & Company Secretary	4,76M	N/A	N/A
Mr. G. P. Prasad	Senior Vice President of Global Finance & Operations	N/A	N/A	N/A
Dr. Sudhir Bimal Singhi	Head of Global Finance Operations	N/A	N/A	1969
Dr. A. Rama Mohana Rao	President of Corporate QA	N/A	N/A	1962

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in INR.

Beschreibung

Aurobindo Pharma Limited engages in manufacturing of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, and internationally. It offers formulation in form of orals, injectables and over-the-counter drugs; and active pharmaceutical ingredients (API) for biosimilars, dermatology, respiratory, vaccines, and peptides, as well as oncology, hormones, and sterile products. The company also provides antiretroviral drugs for the people and children living with HIV; and AuroZymes, a biocatalysts product for use in the pharmaceutical and chemical industries. In addition, it offers AuroSource, a contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for penicillin's, cephalosporins, and non beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

Corporate Governance

Aurobindo Pharma Limiteds ISS Governance QualityScore, Stand 1. Juli 2024, lautet 1. Die grundlegenden Scores sind Audit: 6, Vorstand: 2, Shareholderrechte: 1, Kompensation: 1.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.